eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Sandoz Limited

200 Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, UK
Telephone: +44 (0) 1276 698020
Fax: +44 (0) 1276 698324
WWW: http://www.sandoz.com
Medical Information e-mail: sandoz@professionalinformation.co.uk
Medical Information Fax: +44 (0) 1276 698468

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 31/08/2011
SPC Tranexamic Acid 500mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   01-Jun-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Amended text (shown in red).

4.8 Undesirable effects

 

Adverse events are listed below by system organ class and frequency.

 

Frequencies are defined as: very common (=1/l0), common (=1/100 to <1/10), uncommon (=1/1000 to <1/100), rare ( =1/10,000 to <1/1000) and very rare (<1/10,000), not known (cannot be estimated from the available data).

 

Immune system disorders

Very rare: Hypersensitivity reactions including anaphylaxis

 

Nervous System Disorders

Very rare: convulsions, particularly in case of misuse

 

Eye disorders

Rare: Colour vision disturbances, retinal vein/artery occlusion

 

Vascular disorders

Rare: Thromboembolic events

Very rare: Arterial or venous thrombosis at any sites. Malaise with hypotension, with or without loss of consciousness (generally following a too fast intravenous injection, exceptionally after oral administration).

 

Gastro-intestinal disorders

Very rare: Digestive effects such as nausea, vomiting and diarrhoea.

 

Skin and subcutaneous tissue disorders
Rare: Allergic skin reactions

Updated on 03/03/2011 and displayed until 31/08/2011
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

None provided

Active Ingredients/Generics

 
   tranexamic acid